BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 8120790)

  • 1. Application of co-precipitated glutinous rice starch as a multifunctional excipient in direct compression tablets.
    Amornrojvaravut C; Peerapattana J
    Heliyon; 2023 Sep; 9(9):e19904. PubMed ID: 37809676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of three chitin metal silicate co-precipitates as a potential multifunctional single excipient in tablet formulations.
    Hamid RA; Al-Akayleh F; Shubair M; Rashid I; Remawi MA; Badwan A
    Mar Drugs; 2010 May; 8(5):1699-715. PubMed ID: 20559493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre and post characterization of ODTs with emphasis on compression force and quality of super-disintegrants: In vivo analysis in healthy volunteers.
    Ayub S; Hanif S; Ul Huq UI; Irfan M; Ali I; Madkhali OA; Farzana K; Ali Syed M; Shahid N; Aftab T; Asmatullah M
    Pak J Pharm Sci; 2023 Nov; 36(6):1767-1775. PubMed ID: 38124417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging a multivariate approach towards enhanced development of direct compression extended release tablets.
    Sousa AS; Serra J; Estevens C; Costa R; Ribeiro AJ
    Int J Pharm; 2023 Nov; 646():123432. PubMed ID: 37739095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrins: Emerging Medicines of the New Millennium.
    Braga SS
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31795222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent.
    Late SG; Banga AK
    AAPS PharmSciTech; 2010 Dec; 11(4):1627-35. PubMed ID: 21086083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myxoid leiomyosarcoma of the esophagus].
    Aiko S; Sugiura Y; Yoshizumi Y; Ogawa H; Watanabe M; Tanaka S
    Jpn J Thorac Cardiovasc Surg; 1998 May; 46(5):465-72. PubMed ID: 9654929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrins as excipients in tablet formulations.
    Conceição J; Adeoye O; Cabral-Marques HM; Lobo JMS
    Drug Discov Today; 2018 Jun; 23(6):1274-1284. PubMed ID: 29689302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct compression high functionality excipient using coprocessing technique: a brief review.
    Mirani AG; Patankar SP; Borole VS; Pawar AS; Kadam VJ
    Curr Drug Deliv; 2011 Jul; 8(4):426-35. PubMed ID: 21235470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cyclodextrin as a direct compression excipient compared to conventional ones.
    Saleh SI
    J Pharm Belg; 1993; 48(5):371-7. PubMed ID: 8120790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New multifunctional pharmaceutical excipient in tablet formulation based on citric acid-cyclodextrin polymer.
    Garcia-Fernandez MJ; Tabary N; Chai F; Cazaux F; Blanchemain N; Flament MP; Martel B
    Int J Pharm; 2016 Sep; 511(2):913-20. PubMed ID: 27473278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of modified starches in direct compression of a poorly water soluble drug (hydrochlorothiazide).
    Okafor IS; Ofoefule SI; Udeala OK
    Boll Chim Farm; 2001; 140(1):36-9. PubMed ID: 11338775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of direct compression excipients on the stability of ascorbic acid (vitamin c) tablets.
    Ofoefule SI; Chukwube VO; Attama AA
    Boll Chim Farm; 1999 Sep; 138(8):418-21. PubMed ID: 10622107
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.